WJM-921

N/A

Report date: 2023/02/23 16:43:43
NME

Base Information

Drug NameWJM-921
Drug Alias NameWJM-921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-type ATPase4 inhibitors
TargetsP-type ATPase4
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Melbourne
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Melbourne
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A